XENGLU 25MG 28S TAB

• Xenglu 25 mg contains Empagliflozin 25 mg, an SGLT‑2 inhibitor used alongside diet and exercise to manage type 2 diabetes mellitus in adults. It also helps reduce the risk of cardiovascular death in those with existing heart disease 

Key Usage Info & Side Effects

uses

• For lowering blood sugar in adult type 2 diabetics.

• May reduce cardiovascular mortality in patients with both type 2 diabetes and heart disease 

Common Side Effects

• Increased urination, genital or urinary tract infections (including vaginitis, balanitis)

• Hypoglycemia (esp. when combined with insulin or sulfonylureas)

• Nausea, headache, dehydration, and possible volume depletion